IM Cannabis (IMCC) Payables (2019 - 2026)

IM Cannabis' Payables history runs 8 years deep, the most recent figure standing at $6.0 million for Q1 2026.

• On a quarterly basis, Payables fell 44.41% year-over-year to $6.0 million in Q1 2026; TTM through Mar 2026 was $6.0 million, a 44.41% decrease from a year earlier, with the FY2025 full-year figure at $18.9 million, down 1.51% from the prior year.
• Payables slipped to $6.0 million in Q1 2026 per IMCC's latest filing, from $18.9 million in the prior quarter.
• Across five years, Payables topped out at $26.0 million in Q2 2022 and bottomed at $5.2 million in Q3 2025.
• The 5-year median for Payables is $15.7 million (2023), against an average of $15.6 million.
• Across the five-year window, Payables surged 70.81% in 2022 and slumped 75.78% in 2025, its largest moves.
• Year by year, Payables stood at $18.1 million in 2022, then decreased by 13.35% to $15.7 million in 2023, then grew by 20.11% to $18.8 million in 2024, then rose by 0.49% to $18.9 million in 2025, then slumped by 68.38% to $6.0 million in 2026.
• Per Business Quant, the three latest IMCC Payables figures stand at $6.0 million (Q1 2026), $18.9 million (Q4 2025), and $5.2 million (Q3 2025).